OrisDX Press Releases - EIN Presswire - Press Release Distribution Service

Published on August 26, 2026 - 15:19 GMT

OrisDX Opens Early Access Program for Oro Lesion: The First Non-Invasive Salivary DNA Test for Oral Cancer Detection

Dental Practices Can Now Secure Priority Shipment for the Revolutionary Oral Cancer Molecular Diagnostic Test Ahead of National Commercial Launch. CHICAGO, IL, UNITED STATES, August 26, 2026 /⁨EINPresswire.com⁩/ -- OrisDX, a pioneer in molecular salivary …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 27, 2026 - 16:31 GMT

OrisDX and HPV Cancers Alliance Partner to Break the Silence on Oral Cancer During National Awareness Month

Bridging clinical innovation and patient advocacy to drive early detection and humanize the fight against HPV-Related oral cancers. CHICAGO, IL, UNITED STATES, April 27, 2026 /⁨EINPresswire.com⁩/ -- In observance of Oral Cancer Awareness Month, OrisDX, a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 7, 2026 - 21:10 GMT

OrisDX and Teledentistry.com Announce Strategic Partnership to Expand Access to Early Oral Cancer Detection

Combining virtual dental care with licensed dentists and an innovative oral cancer diagnostics solution ensures all patients will receive the care they deserve. CHICAGO, IL, UNITED STATES, January 7, 2026 /⁨EINPresswire.com⁩/ -- OrisDX, a pioneer in …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on October 16, 2025 - 17:01 GMT

OrisDX Founder Lab at University of Chicago Awarded $250,000 to Enhance Oral Cancer Detection Technology

OrisDX receives $250K CBC award to boost HPV oral cancer test, launches new site, and heads to HLTH 2025. CHICAGO, IL, UNITED STATES, October 16, 2025 /⁨EINPresswire.com⁩/ -- OrisDX is proud to announce that the Founders of OrisDX Lab at the University of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 10, 2025 - 12:15 GMT

OrisDX Raises $4M Seed to Launch First-of-Its-Kind Saliva-Based Multiomic Platform, Targeting Oral Cancer

Pioneering saliva-based multiomic platform from Chicago secures $4M Seed from leading East and West coast investors to transform early oral cancer detection CHICAGO, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- OrisDX, a precision diagnostics …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...